BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24379124)

  • 1. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.
    Palanichamy A; Bauer JW; Yalavarthi S; Meednu N; Barnard J; Owen T; Cistrone C; Bird A; Rabinovich A; Nevarez S; Knight JS; Dedrick R; Rosenberg A; Wei C; Rangel-Moreno J; Liesveld J; Sanz I; Baechler E; Kaplan MJ; Anolik JH
    J Immunol; 2014 Feb; 192(3):906-18. PubMed ID: 24379124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression.
    Han JH; Umiker BR; Kazimirova AA; Fray M; Korgaonkar P; Selsing E; Imanishi-Kari T
    Eur J Immunol; 2014 Jan; 44(1):215-26. PubMed ID: 24105635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.
    Jacob N; Guo S; Mathian A; Koss MN; Gindea S; Putterman C; Jacob CO; Stohl W
    J Immunol; 2011 Apr; 186(8):4984-93. PubMed ID: 21383240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.
    Zhuang H; Han S; Xu Y; Li Y; Wang H; Yang LJ; Reeves WH
    Arthritis Rheumatol; 2014 Jan; 66(1):140-51. PubMed ID: 24449581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice.
    Jacob CO; Guo S; Jacob N; Pawar RD; Putterman C; Quinn WJ; Cancro MP; Migone TS; Stohl W
    Arthritis Rheum; 2012 May; 64(5):1610-9. PubMed ID: 22127792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.
    Ben-David H; Sharabi A; Parameswaran R; Zinger H; Mozes E
    Immunology; 2009 Oct; 128(2):245-52. PubMed ID: 19740381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen.
    Lee MH; Chakhtoura M; Sriram U; Caricchio R; Gallucci S
    J Immunol Res; 2018; 2018():1601079. PubMed ID: 29850618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients.
    Liu M; Guo Q; Wu C; Sterlin D; Goswami S; Zhang Y; Li T; Bao C; Shen N; Fu Q; Zhang X
    Cell Mol Immunol; 2019 Apr; 16(4):367-379. PubMed ID: 29563616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
    Dong G; Yang Y; Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Zhang J; Shi H; Ning Z; Yan F; Zhai W; Dai J; Li Z; Li C; Ming J; Xue Q; Meng X; Si C; Xiong H
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165554. PubMed ID: 31513833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Murine Systemic Lupus Erythematosus in the Absence of BAFF.
    Stohl W; Yu N; Chalmers S; Putterman C; Jacob CO
    Arthritis Rheumatol; 2020 Feb; 72(2):292-302. PubMed ID: 31493335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
    Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
    Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
    Pau E; Chang NH; Loh C; Lajoie G; Wither JE
    Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus.
    El-Sherbiny YM; Md Yusof MY; Psarras A; Hensor EMA; Kabba KZ; Dutton K; Mohamed AAA; Elewaut D; McGonagle D; Tooze R; Doody G; Wittmann M; Emery P; Vital EM
    Arthritis Rheumatol; 2020 May; 72(5):769-779. PubMed ID: 31804007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
    Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
    Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice.
    Coquery CM; Wade NS; Loo WM; Kinchen JM; Cox KM; Jiang C; Tung KS; Erickson LD
    PLoS One; 2014; 9(7):e102284. PubMed ID: 25010693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.
    Garcia-Romo GS; Caielli S; Vega B; Connolly J; Allantaz F; Xu Z; Punaro M; Baisch J; Guiducci C; Coffman RL; Barrat FJ; Banchereau J; Pascual V
    Sci Transl Med; 2011 Mar; 3(73):73ra20. PubMed ID: 21389264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon
    Akita K; Yasaka K; Shirai T; Ishii T; Harigae H; Fujii H
    Front Immunol; 2020; 11():498703. PubMed ID: 33633721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease.
    Scott JL; Wirth JR; EuDaly JG; Gilkeson GS; Cunningham MA
    Clin Immunol; 2017 Feb; 175():109-114. PubMed ID: 28041989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.